Authors:
HARTMANN M
EHRLICH A
FUDER H
LUHMANN R
EMEKLIBAS S
TIMMER W
WURST W
LUCKER PW
Citation: M. Hartmann et al., EQUIPOTENT INHIBITION OF GASTRIC-ACID SECRETION BY EQUAL DOSES OF ORAL OR INTRAVENOUS PANTOPRAZOLE, Alimentary pharmacology & therapeutics, 12(10), 1998, pp. 1027-1032
Citation: W. Timmer et al., 24-HOUR RECORDING OF INTRAGASTRIC PH IN CLINICAL-TRIALS - PRECONDITIONS, METHODOLOGY, AND STANDARDIZATION STRATEGIES, Journal of clinical pharmacology, 37(1), 1997, pp. 34-39
Authors:
KLEIST P
EHRLICH A
SUZUKI Y
TIMMER W
WETZELSBERGER N
LUCKER PW
FUDER H
Citation: P. Kleist et al., CONCOMITANT ADMINISTRATION OF THE ALPHA-GLUCOSIDASE INHIBITOR VOGLIBOSE (AO-128) DOES NOT ALTER THE PHARMACOKINETICS OF GLIBENCLAMIDE, European Journal of Clinical Pharmacology, 53(2), 1997, pp. 149-152
Authors:
EHRLICH A
FUDER H
HARTMANN M
WIECKHORST G
TIMMER W
HUBER R
BIRKEL M
BLIESATH H
STEINIJANS VW
WURST W
LUCKER PW
Citation: A. Ehrlich et al., LACK OF PHARMACODYNAMIC AND PHARMACOKINETIC INTERACTION BETWEEN PANTOPRAZOLE AND PHENPROCOUMON IN MAN, European Journal of Clinical Pharmacology, 51(3-4), 1996, pp. 277-281
Authors:
FUDER H
KLEIST P
EHRLICH A
TIMMER W
SUZUKI Y
BIRKEL M
WETZELSBERGER N
LUCKER PW
Citation: H. Fuder et al., NO PHARMACOKINETIC INTERACTION BETWEEN THE ALPHA-GLUCOSIDASE INHIBITOR VOGLIBOSE (AO-128) AND GLIBENCLAMIDE IN HEALTHY-SUBJECTS, Naunyn-Schmiedeberg's archives of pharmacology, 354(4), 1996, pp. 123-123
Authors:
TIMMER W
RIPKE H
KLEIST P
EHRLICH A
WIECKHORST G
LUCKER PW
FUDER H
Citation: W. Timmer et al., EFFECT OF 4 LANSOPRAZOLE DOSE LEVELS AND ONE DOSAGE REGIMEN OF OMEPRAZOLE ON 24-HOUR INTRAGASTRIC PH IN HEALTHY-SUBJECTS, Methods and findings in experimental and clinical pharmacology, 17(7), 1995, pp. 489-495
Authors:
EHRLICH A
FUDER H
HARTMANN M
TIMMER W
HUBER R
BIRKEL M
BLIESATH H
STEINJIANS VW
WURST W
LUCKER PW
Citation: A. Ehrlich et al., LACK OF PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION OF PANTOPRAZOLE AND PHENPROCOUMON IN MAN, Gastroenterology, 108(4), 1995, pp. 86-86
Authors:
FUDER H
HARTMANN M
TIMMER W
LUHMANN R
WIECKHORST G
HUBER R
BLIESATH H
WURST W
POSTIUS S
RADTKE HW
LUCKER PW
Citation: H. Fuder et al., 1ST ADMINISTRATION TO MAN OF THE NEW REVERSIBLE PROTON PUMP INHIBITOR-BY841 - TOLERABILITY, SAFETY AND PH-METRY, Gastroenterology, 108(4), 1995, pp. 96-96
Authors:
THEISS U
TIMMER W
WIECKHORST G
MACCIOCCHI A
WETZELSBERGER N
Citation: U. Theiss et al., INVESTIGATION INTO A POSSIBLE DRUG-DRUG INTERACTION BETWEEN WARFARIN AND NIMESULIDE IN HEALTHY-VOLUNTEERS, Methods and findings in experimental and clinical pharmacology, 15(9), 1993, pp. 629-635